COMMUNIQUÉS West-GlobeNewswire
-
RYBREVANT®▼ (amivantamab) associé à une chimiothérapie montre une tendance de survie globale positive par rapport à la chimiothérapie chez les patients atteints d'un cancer du poumon muté par EGFR préalablement traité
16/09/2024 - 16:00 -
ARC Fertility Sponsors Purchaser Business Group on Health 2024 Maternal Health and Birth Equity Summit
16/09/2024 - 16:02 -
L’association RYBREVANT®▼ (amivantamab) plus chimiothérapie démontre un taux de réponse globale de 49 pour cent dans le cancer colorectal métastatique
16/09/2024 - 16:11 -
Trading by management and close relations of management
16/09/2024 - 16:14 -
Capsa Healthcare’s New Interactive Website Assists Healthcare Leaders in Technology Decision Making
16/09/2024 - 16:16 -
Impact BioMedical Inc. Announces Pricing of Initial Public Offering
16/09/2024 - 16:24 -
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
16/09/2024 - 16:47 -
Kairos Pharma Prices $6.2 Million Initial Public Offering
16/09/2024 - 16:49 -
Props.Cash Bolsters Responsible Gaming Offering with Birches Health Partnership
16/09/2024 - 17:20 -
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT 2024
16/09/2024 - 18:44 -
Sanofi: Information concerning the total number of voting rights and shares - August 2024
16/09/2024 - 18:44 -
KFSHRC Deputy CEO Receives Global Innovative Healthcare & Impact Transformation Award at New York Summit
16/09/2024 - 20:06 -
KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations
16/09/2024 - 21:06 -
ImmuneSensor Therapeutics to Participate in the UBS 2024 Virtual Biotechnology Private Company Symposium
16/09/2024 - 22:00 -
Galapagos receives transparency notification from EcoR1 Capital
16/09/2024 - 22:01 -
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
16/09/2024 - 22:01 -
Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
16/09/2024 - 22:01 -
Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference
16/09/2024 - 22:05 -
89bio Announces Appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer
16/09/2024 - 22:05
Pages